Company Filing History:
Years Active: 2013
Title: Innovations by Kim Bjornstrup in Blood Plasma Stabilization
Introduction
Kim Bjornstrup is an accomplished inventor based in Feusisberg, Switzerland. He has made significant contributions to the field of biomedical engineering, particularly in the stabilization of blood plasma components. His innovative approach has the potential to enhance the preservation and usability of blood products.
Latest Patents
Kim holds a patent for a method titled "Method for stabilizing blood plasma components in a lyophilizate using carbon dioxide and phosphoric acid." This process focuses on the stabilization of blood plasma components in a lyophilizate, which is crucial for maintaining the integrity and functionality of these components during storage.
Career Highlights
Kim Bjornstrup is currently associated with Octapharma AG, a leading company in the development and production of human proteins. His work at Octapharma AG has allowed him to apply his innovative ideas in a practical setting, contributing to advancements in the medical field.
Collaborations
Throughout his career, Kim has collaborated with notable colleagues, including Martin Kern and Andrea Heger. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise.
Conclusion
Kim Bjornstrup's contributions to the stabilization of blood plasma components represent a significant advancement in biomedical technology. His innovative methods and collaborations continue to impact the field positively.